State legislation aiming to block discriminatory practices used against pharmacies in a federal drug discount program is ramping up this year despite legal challenges from the drug industry.
The Community Oncology Alliance (COA), which represents independent cancer care practices, has asked CMS to act following a dramatic drop in reimbursements from Express Scripts, Inc. effective January 1, 2024.